Table 1

Baseline Demographic Data and Clinical Characteristics

Bivalirudin (n = 125)UFH (n = 111)p Value
Variable
 Age (yrs)69.9 ± 10.4371.2 ± 11.880.3724
 Male71 (56.8%)51 (46.0%)0.1250
 CAD98 (78.4%)90 (81.1%)0.7271
 Diabetes mellitus56 (44.8%)45 (40.5%)0.5975
 Hypertension96 (76.8%)82 (73.9%)0.7114
 Dyslipidemia78 (62.4%)74 (66.7%)0.5837
 Obesity (BMI >30 kg/m2)70 (56.0%)54 (48.7%)0.3183
 Current cigarette smoker35 (28.0%)28 (25.2%)0.7391
Medications (pre-procedure)
 ASA113 (90.4%)103 (92.8%)0.6716
 Clopidogrel46 (36.8%)45 (40.5%)0.6491
 Warfarin10 (8.0%)3 (2.7%)0.1349

ASA = acetylsalicylic acid; BMI = body mass index; CAD = coronary artery disease; UFH = unfractionated heparin.